InvestorsHub Logo
icon url

tendies

08/20/20 10:07 AM

#10880 RE: Clarnold #10876

“Aight guys, we found a drug that works. Covid hype is over, better sell everything and get back to investing in corn futures”
icon url

nelskof

08/20/20 10:08 AM

#10882 RE: Clarnold #10876

The 21 patient update still needs to be officially peer reviewed and published.

Geneva, Switzerland and Radnor, PA August 20, 2020 – RELIEF THERAPEUTICS Holdings SA (SIX:RLF) and NeuroRx, Inc. announce that clinical findings in the first 21 patients treated with RLF-100 (aviptadil) under FDA Emergency Use Investigational New Drug (IND) authorization and Expanded Access Protocol authorization have been submitted by investigators at the Houston Methodist Hospital as a preprint to the SSRN server maintained by Elsevier[1]. The manuscript has been submitted for peer review to a leading scientific journal.
icon url

maximumgriff

08/20/20 10:10 AM

#10887 RE: Clarnold #10876

Can’t fix stupid or ignorance, No news, a PR will come when peer review happens.